Jennison Associates’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-38,359
| Closed | -$689K | – | 626 |
|
|
2023
Q4 | $689K | Buy |
38,359
+493
| +1% | +$8.85K | ﹤0.01% | 536 |
|
|
2023
Q3 | $623K | Buy |
37,866
+334
| +0.9% | +$5.5K | ﹤0.01% | 519 |
|
|
2023
Q2 | $750K | Buy |
37,532
+2,304
| +7% | +$46.1K | ﹤0.01% | 515 |
|
|
2023
Q1 | $666K | Sell |
35,228
-6,127
| -15% | -$116K | ﹤0.01% | 545 |
|
|
2022
Q4 | $938K | Sell |
41,355
-1,049
| -2% | -$23.8K | ﹤0.01% | 494 |
|
|
2022
Q3 | $1.12M | Sell |
42,404
-3,164
| -7% | -$83.6K | ﹤0.01% | 492 |
|
|
2022
Q2 | $1.13M | Buy |
45,568
+15,577
| +52% | +$385K | ﹤0.01% | 505 |
|
|
2022
Q1 | $995K | Buy |
+29,991
| New | +$995K | ﹤0.01% | 562 |
|
|
2017
Q1 | – | Sell |
-292,268
| Closed | -$5.42M | – | 761 |
|
|
2016
Q4 | $5.42M | Buy |
292,268
+246
| +0.1% | +$4.56K | 0.01% | 503 |
|
|
2016
Q3 | $4.09M | Sell |
292,022
-380
| -0.1% | -$5.32K | ﹤0.01% | 508 |
|
|
2016
Q2 | $2.34M | Buy |
292,402
+14
| +0% | +$112 | ﹤0.01% | 520 |
|
|
2016
Q1 | $3.16M | Sell |
292,388
-45,690
| -14% | -$493K | ﹤0.01% | 504 |
|
|
2015
Q4 | $5.56M | Sell |
338,078
-17,266
| -5% | -$284K | 0.01% | 507 |
|
|
2015
Q3 | $7.67M | Buy |
+355,344
| New | +$7.67M | 0.01% | 511 |
|